Two novel regimens showed significant anti-tumor activity in patients with neuroblastoma.
Intermittent docetaxel could be an option for patients with CRPC.
Gemcitabine plus capecitabine improves survival for patients with pancreatic cancer
Aspirin exposure is associated with improved CRC-specific survival.
Cediranib in conjunction with lenalidomide is evidently not a more effective therapy for patients with advanced differentiated thyroid cancer (DTC).
Drugs such as idelalisib may frequently cause immune-mediated hepatotoxicity in chronic lymphocytic leukemia (CLL).
Pembrolizumab may be an effective treatment for patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Previously treated patients with advanced non-small-cell lung cancer (NSCLC) ought to receive pembrolizumab.
Poor OS in women with bladder cancer may be attributable to the lower frequency of women being treated with systemic chemotherapy.
